Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Hypnotic agent in the Fujisawa pipeline

Oct. 11, 1996

U.S. approval for anesthetic/analgesic agent

Oct. 11, 1996

Ciba-Geigy reports on further NK1 antagonists

Oct. 11, 1996

New analgesic drugs presented at 8th World Congress on Pain

Oct. 11, 1996

Calpain inhibitors from Fujirebio

Oct. 4, 1996

Astra NOS inhibitors as neuroprotectants

Oct. 4, 1996

Divalproex reduces cognitive deficits associated with lithium

Oct. 4, 1996

Genzyme-Diacrin joint venture for porcine neural cell products

Oct. 4, 1996

Spanish investigators report MAO inhibitors

Oct. 4, 1996

MRC scientists investigate estrogen's role in psychological disorders

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...